Insider trading

Period: 120 months Stock: AGL Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

134 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

134 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

134 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

134 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
134 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
134 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

134 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
9 Mar 2026
Shaker Benjamin Chief Markets Officer
Bought
no price 18,448 shares
1.3%
9 Mar 2026
Venkatachaliah Girish Chief Technology Officer
Bought
no price 18,448 shares
6.9%
9 Mar 2026
Zamore Denise Chief Legal Officer
Bought
no price 5,535 shares
1.2%
First buy on file
2 Mar 2026
Shaker Benjamin Chief Markets Officer
Bought
$301.05K 500,000 at 0.60
57.6%
Largest buy in 3 yrs
12 Nov 2025
Bought
$50.94K 81,000 at 0.63
28.4%
+28% of stake
14 Mar 2025
Venkatachaliah Girish Chief Technology Officer
Bought
no price 9,429 shares
6.3%
14 Mar 2025
Shaker Benjamin Chief Markets Officer
Bought
no price 11,786 shares
2.6%
14 Mar 2025
Sell Steven CEO & President
Bought
no price 42,426 shares
12.9%
13 Dec 2024
McLoughlin Karen Director
Bought
$55.09K 25,000 at 2.20
51.9%
First buy on file
11 Dec 2024
Bought
$50.27K 25,062 at 2.01
61.0%
First buy on file
9 Dec 2024
MCKENZIE DIANA Director
Bought
$16.49K 7,500 at 2.20
14.6%
5 Dec 2024
Bought
$98.15K 45,000 at 2.18
27.9%
First buy on file
25 Nov 2024
MCKENZIE DIANA Director
Bought
$28.47K 12,500 at 2.28
32.2%
First buy on file
12 Sep 2024
Sell Steven CEO & President · indirect
Bought
$67.19K 20,000 at 3.36
42.0%
+42% of stake
14 Mar 2024
Bensley Timothy Chief Financial Officer
Bought
no price 14,945 shares
42.5%
First buy on file
14 Mar 2024
Desai Veeral Chief Strategy & Dev. Officer
Bought
no price 11,956 shares
4.0%
First buy on file
14 Mar 2024
Shaker Benjamin Chief Markets Officer
Bought
no price 274,455 shares
345%
First buy on file
14 Mar 2024
Venkatachaliah Girish Chief Technology Officer
Bought
no price 5,434 shares
14.9%
First buy on file
14 Mar 2024
Kornitzer Benjamin Chief Med. & Quality Officer
Bought
no price 5,434 shares
9.3%
First buy on file
29 Nov 2023
Bought
$250.21K 22,300 at 11.22
232%
First buy on file
21 Nov 2023
Sell Steven CEO & President · indirect
Bought
$497.74K 44,690 at 11.14
×15
Largest buy in 3 yrs
11 Sep 2023
Gertsch Timothy Chief Accounting Officer
Sold at will 2×
$488.62K 26,250 at 18.61
60.5%
Sold half or more
15 Jun 2023
Shaker Benjamin Chief Markets Officer
Sold at will
$351.10K 18,750 at 18.73
19.1%
Not planned
14 Jun 2023
Shaker Benjamin Chief Markets Officer
Sold at will 3×
$348.15K 18,750 at 18.57
19.1%
Not planned
18 May 2023
CD&R Investment Associates IX, Ltd. 10% owner · indirect
Sold at will
$1.96B 94,173,804 at 20.80
48.5%
Not planned
24 Mar 2023
Desai Veeral Chief Strategy & Dev. Officer
Sold at will
$2.79M 97,290 at 28.70
26.0%
Not planned
23 Mar 2023
Desai Veeral Chief Strategy & Dev. Officer
Sold at will
$651.91K 22,710 at 28.71
7.6%
Not planned
23 Mar 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold at will
$226.98K 8,094 at 28.04
12.7%
Not planned
22 Mar 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold at will
$225.38K 8,094 at 27.84
12.7%
Not planned
16 Mar 2023
Desai Veeral Chief Strategy & Dev. Officer
Sold, plan not stated
$1.57M 60,000 at 26.09
17.8%
16 Mar 2023
Shaker Benjamin Chief Markets Officer
Sold, plan not stated 3×
$639.90K 25,000 at 25.60
29.2%
15 Mar 2023
Sold, plan not stated
$1.91M 80,000 at 23.82
39.3%
15 Mar 2023
Shaker Benjamin Chief Markets Officer
Sold, plan not stated 2×
$1.43M 60,000 at 23.81
49.7%
15 Mar 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$1.31M 55,000 at 23.81
49.8%
8 Mar 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$197.82K 8,094 at 24.44
43.7%
7 Mar 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$197.20K 8,094 at 24.36
43.7%
15 Feb 2023
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$667.34K 28,555 at 23.37
52.7%
Sold half or more
15 Feb 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$186.03K 8,094 at 22.98
43.7%
14 Feb 2023
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$1.15M 50,000 at 22.98
66.1%
Sold half or more
14 Feb 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$594.88K 25,881 at 22.99
71.3%
Sold half or more
2 Feb 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$707.56K 30,782 at 22.99
74.7%
Sold half or more
1 Feb 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$117.42K 5,396 at 21.76
34.1%
20 Jan 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$107.50K 5,396 at 19.92
34.1%
19 Jan 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$212.94K 10,792 at 19.73
50.9%
Sold half or more
18 Jan 2023
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$409.89K 20,723 at 19.78
44.7%
17 Jan 2023
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$512.23K 25,722 at 19.91
50.1%
Sold half or more
6 Jan 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$41.70K 2,698 at 15.46
20.6%
5 Jan 2023
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$41.85K 2,698 at 15.51
20.6%
16 Dec 2022
Kornitzer Benjamin Chief Med. & Quality Officer
Sold, plan not stated
$90.81K 5,398 at 16.82
34.1%
15 Dec 2022
Shaker Benjamin Chief Markets Officer
Sold, plan not stated
$323.66K 18,750 at 17.26
42.3%
Showing 1–50 of 134. Page 1 of 3 Older →